Skip to search formSkip to main contentSkip to account menu

Gastro-enteropancreatic neuroendocrine tumor

Known as: Gastroenteropancreatic neuroendocrine tumor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background/Aims Neuroendocrine tumors (NETs) may originate from heterogeneous neuroendocrine cells. The incidence is increasing… 
2017
2017
Background/Aims: Somatostatin receptor (SSTR) scintigraphy (SRS) is the standard imaging modality for evaluation of… 
Review
2016
Review
2016
Peptide receptor radionuclide therapy (PRRT) has been utilized for more than two decades and has been accepted as an effective… 
Highly Cited
2014
Highly Cited
2014
The tumor proliferation marker, Ki-67 index, is a well-established prognostic marker in gastroenteropancreatic neuroendocrine… 
Review
2014
Review
2014
AIMS With the aim to improve peptide receptor radionuclide therapy effects in patients with gastroenteropancreatic neuroendocrine… 
2013
2013
According to the international guidelines, a multidisciplinary approach is currently advised for the optimal care of patients… 
2013
2013
PurposePasireotide (SOM230), a novel multireceptor ligand somatostatin analog (SSA), binds with high affinity to four of the five… 
Review
2012
Review
2012
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominantly inherited endocrine tumor syndrome characterized by tumor… 
2009
2009
Nuclear factor-κB (NF-κB) is a transcription factor responsible for modulating the expression of many genes involved in immune…